Tissues, Cells and Biomarkers in ARDS

authors:

avatar Seyed Mohammad Reza Hashemian 1 , * , avatar Hedayatollah Elyasi , avatar Ali Dabbagh ORCID

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Journal of Cellular & Molecular Anesthesia: Vol.1, issue 1; e150238
article type: Letter to the Editor
DOI: https://doi.org/10.22037/jcma.v1i1.10576

how to cite: Hashemian S M R, Elyasi H, Dabbagh A. Tissues, Cells and Biomarkers in ARDS. J Cell Mol Anesth. 2016;1(1):e150238. https://doi.org/10.22037/jcma.v1i1.10576.

Abstract

?The utility of biomarkers for the action of endothelium and epithelium of the pulmonary microvasculars is unknown and their action of being barrier for edema and dysfunction of them cause ARDS and its mortality rate with no specific drugs efficiency is high (1). Recently, there are many important information about biomarkers in ARDS (2). These biomarkers in ARDS can effect either cellular activation or cell injury. Currently, biomarkers are the most important research tool. The biomarkers have an important role in ARDS treatment in the function. There is an executive phase with some damage like edema and necroses. Then, fibro-proliferative phase will be happen. To understand the mechanism of repair, we focus on the function of alveolar type I (3). ?